Mustang Bio, Inc. financial data

Symbol
MBIO on Nasdaq
Location
377 Plantation Street, Worcester, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 53.3 % -83.4%
Debt-to-equity -320 % -347%
Return On Equity 430 %
Return On Assets -195 % -67.9%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 106M shares +16.7%
Entity Public Float 38.7M USD -20.7%
Weighted Average Number of Shares Outstanding, Basic 36.8M shares +351%
Weighted Average Number of Shares Outstanding, Diluted 36.8M shares +351%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 6.54M USD -34%
Operating Income (Loss) -24M USD +60%
Nonoperating Income (Expense) 553K USD -81.1%
Net Income (Loss) Attributable to Parent -23.4M USD +62.6%
Earnings Per Share, Basic -1.56 USD/shares +79.9%
Earnings Per Share, Diluted -1.56 USD/shares +79.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.53M USD -63.1%
Assets, Current 6.06M USD -55.4%
Property, Plant and Equipment, Net 421K USD -88%
Operating Lease, Right-of-Use Asset 92K USD -94.4%
Other Assets, Noncurrent 250K USD -76.9%
Assets 7.19M USD -65%
Accounts Payable, Current 8.76M USD +59.3%
Liabilities, Current 15M USD +6.16%
Operating Lease, Liability, Noncurrent 541K USD -74.5%
Liabilities 15.8M USD -4.28%
Retained Earnings (Accumulated Deficit) -396M USD -6.29%
Stockholders' Equity Attributable to Parent -8.66M USD -316%
Liabilities and Equity 7.19M USD -65%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.32M USD +70.1%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 7.32M shares -93%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.9M USD -62.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 148M USD +15.3%
Deferred Tax Assets, Gross 148M USD +14.8%
Operating Lease, Liability 983K USD -61.8%
Depreciation 893K USD -61.8%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 1.08M USD -66%
Property, Plant and Equipment, Gross 7.69M USD 0%
Operating Lease, Liability, Current 442K USD -2.43%
Lessee, Operating Lease, Liability, to be Paid, Year Two 439K USD -43.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 516K USD -28.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 99K USD -83.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 269K USD -61.7%
Deferred Tax Assets, Operating Loss Carryforwards 84.7M USD +12.9%
Preferred Stock, Shares Issued 250K shares 0%
Preferred Stock, Shares Authorized 2M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 274K USD +1.86%
Operating Lease, Payments 156K USD +18.2%
Preferred Stock, Shares Outstanding 250K shares 0%
Deferred Tax Assets, Net of Valuation Allowance 582K USD -46.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%